About
Gerium Medical is the developer of BiliCare, a noninvasive bilirubin meter for newborns.BiliCares technology is based onspectroscopy, and involves measuring substances using visible and non-visible light at varying wavelengths. The device is CE-marked and used for neonatal jaundice diagnoses. The BiliCare meter measures the level of transcutaneous bilirubin in newborns by transmitting light at different wavelengths through the newborns ear and then measuring the intensity of the wavelengths when they exit the ear. The amount of light absorbed by bilirubin is calculated by comparing the intensity of the light before it enters the tissue with its intensity after it leaves. The transcutaneous bilirubin of the newborn is then calculated according to a customized algorithm. Gerium Medical was acquired by Redworth Israel Ltd in 2015 and is now operating under Mennen Medical Group.